GI CANCERS

Latest News

ACTION-1: Study Initiates Treatment With RYZ101 in SSTR+ Gastroenteropancreatic NETs
ACTION-1: Study Initiates Treatment With RYZ101 in SSTR+ Gastroenteropancreatic NETs

June 3rd 2023

ACTION-1 is investigating RYZ101 versus standard-of-care therapy in patients with SSTR-positive gastroenteropancreatic neuroendocrine tumors after 177Lu-SSA therapy.

ATG-022 Granted Orphan Drug Status by FDA for 2 Types of GI Cancer
ATG-022 Granted Orphan Drug Status by FDA for 2 Types of GI Cancer

May 23rd 2023

FDA Grants Orphan Drug Designation to Mitazalimab for Pancreatic Cancer
FDA Grants Orphan Drug Designation to Mitazalimab for Pancreatic Cancer

May 23rd 2023

GEN-001/Avelumab Combination Induces Antitumor Activity in Gastric and GEJ Cancer
GEN-001/Avelumab Combination Induces Antitumor Activity in Gastric and GEJ Cancer

May 19th 2023

FDA Grants Orphan Drug Designation to Rucosopasem for Pancreatic Cancer
FDA Grants Orphan Drug Designation to Rucosopasem for Pancreatic Cancer

May 19th 2023

Video Series
Video Interviews
Podcasts

More News